Stage 4 Endometriosis: Symptoms, Diagnosis, and Treatment

Stage 4, or “severe,” endometriosis is the most advanced form on the revised American Society for Reproductive Medicine (rASRM) scoring system, characterized by large, deep implants, substantial adhesions, and often large ovarian endometriomas (blood-filled cysts sometimes called “chocolate cysts”). At this stage, endometrial-like tissue can bind pelvic organs together so thoroughly that surgeons describe the result as a “frozen pelvis,” where the uterus, cervix, uterosacral ligaments, ureters, and rectum lose their normal mobility.¹ Yet the relationship between what stage 4 looks like on imaging or in the operating room and what it feels like day to day is far less straightforward than the staging number implies.

What Makes Stage 4 Different From Earlier Stages

The rASRM staging system assigns points based on the size, depth, and location of implants plus the extent of adhesions. Stage 4 requires a score of 40 or above. In practice, this usually means at least one of the following: bilateral ovarian endometriomas, dense adhesions that distort pelvic anatomy, or deep infiltrating endometriosis (DIE) involving structures like the bowel wall, bladder, or ureters. DIE behaves differently at a cellular level from superficial peritoneal implants. Compared with other endometriosis forms, DIE tissue shows sharply reduced cell death, increased proliferation driven by oxidative stress, and much higher expression of genes that promote nerve growth and new blood vessel formation.² That aggressive biology helps explain why deep lesions tend to produce more severe symptoms and are harder to eradicate than superficial ones.

A frozen pelvis is the hallmark of advanced disease. When the space behind the uterus (the Pouch of Douglas) fills with scar tissue and endometriotic nodules, the uterus and rectum become tethered together. The uterosacral ligaments thicken, ureters can be pulled into the disease, and even the sigmoid colon may be densely adherent. Not every person with a score above 40 has a fully obliterated pelvis, but those who do face a more complex surgical picture and carry higher risks of organ-related complications during treatment.

Symptoms and the Staging Paradox

One of the most frustrating aspects of endometriosis for patients and clinicians alike is that the stage of disease does not reliably predict how much pain someone experiences. A large study of more than 1,000 patients found that the statistical association between rASRM stage and pelvic pain severity was “marginal and inconsistent,” detectable only with very large sample sizes, and the actual size of the effect was tiny.³ A meta-analysis confirmed that overall pain intensity did not differ significantly between early-stage (I/II) and advanced-stage (III/IV) disease, although chronic pelvic pain was more common in advanced stages.⁴

That said, certain symptom patterns do track with the anatomical changes typical of stage 4. Painful intercourse (dyspareunia) is the symptom most clearly linked to higher disease stage, and patients reporting it are roughly five times more likely to have advanced disease.⁵ Dyspareunia severity also correlates with how completely the Pouch of Douglas is scarred shut. Chronic pelvic pain, heavy menstrual bleeding, bowel symptoms during menstruation (painful defecation, bloating, constipation, or diarrhea), and urinary symptoms can all feature prominently. The takeaway: a person with stage 4 disease may have debilitating symptoms across many organ systems, or may have surprisingly manageable pain. Stage describes anatomy, not suffering.

When the Bowel and Urinary Tract Are Involved

The gastrointestinal tract is the most common site of extrapelvic endometriosis. Most bowel lesions sit on the outer surface (serosa) of the rectum or sigmoid colon, but deeper infiltration can alter bowel function and cause cyclical rectal bleeding, severe cramping with bowel movements, and partial obstruction symptoms. Bladder and ureteral involvement are the most common urinary-tract locations. Ureteral endometriosis is particularly concerning because it often causes no urinary symptoms at all, quietly obstructing the ureter and potentially leading to kidney damage if it goes undetected.⁶

When urinary-tract disease is surgically managed, outcomes tend to be favorable. In one surgical series of 30 women with bladder or ureteral endometriosis, most experienced significant improvement in pain and no lingering urinary complaints, though about one in four who had ureteral surgery experienced a complication, and one patient had prolonged bladder nerve dysfunction.⁷ The fact that ureteral disease can be silent is a strong argument for thorough imaging before any stage 4 surgery, so surgeons know what they are walking into.

How Stage 4 Disease Is Diagnosed

Endometriosis can only be definitively staged during surgery, when lesions can be directly inspected and scored. But advanced imaging plays a crucial role in mapping disease before anyone enters the operating room, particularly at this stage where the stakes of missing bowel or ureteral involvement are high.

Transvaginal ultrasound (TVS) is the first-line imaging tool. A key technique is the “sliding sign,” where the sonographer uses the ultrasound probe to see whether the uterus glides freely against the rectum. If it does not, that suggests the Pouch of Douglas is obliterated by adhesions or endometriosis. A systematic review and meta-analysis found the sliding sign had a pooled sensitivity of about 88% and specificity of about 94% for detecting Pouch of Douglas obliteration, with similar performance for identifying bowel involvement.⁸ Combining the sliding sign with direct visualization of nodules on ultrasound can improve specificity further, though at some cost to sensitivity.⁹

MRI is often added when bowel resection or ureteral surgery is being considered. It excels at confirming deep infiltrating lesions, with specificities in the range of roughly 83% to 99% across different pelvic compartments, but its sensitivity is more uneven, dropping as low as 40% in some anatomic locations.¹⁰ In practical terms, a positive MRI finding is highly reliable, but a clean MRI does not rule out endometriosis. This is important context for anyone told their MRI “looks normal” while symptoms persist.

Surgical Treatment and What It Involves

Surgery is the primary treatment for stage 4 disease when pain is severe, organs are at risk, or fertility is the goal. The operation usually involves laparoscopic excision of endometriotic tissue and adhesions, but when deep bowel involvement is present, the procedure becomes considerably more complex and often requires a colorectal surgeon alongside the gynecologist.

There are three main techniques for handling bowel endometriosis, each escalating in how much tissue is removed:

Shaving: the nodule is shaved off the bowel wall without opening it, leaving the inner layers intact.
Disc excision: a full-thickness disc of bowel wall is cut out and the hole is closed.
Segmental resection: a section of bowel is removed entirely and the two ends are reconnected.

These approaches carry different risk profiles. In a comparative study of 364 consecutive cases, serious complications requiring further intervention occurred in about 12% of patients overall, with roughly two-thirds of those concentrated in the segmental resection group. Rectovaginal fistula, a dreaded complication where an abnormal connection forms between the rectum and vagina, occurred in about 4% of cases across all three techniques.¹¹ Segmental resection also takes meaningfully longer in the operating room and results in longer hospital stays compared with shaving or disc excision.¹² A small percentage of patients need a temporary stoma (an external bowel opening) to protect the surgical site while it heals.

Excision Versus Ablation for Endometriotic Implants

Outside the bowel, a longstanding debate exists over whether cutting out lesions (excision) is better than burning them off (ablation). The evidence is genuinely mixed. One meta-analysis found excision produced significantly greater improvements in period pain and painful bowel movements at 12 months compared with ablation.¹³ However, a more recent systematic review found no significant difference between the two techniques for any pain outcome at the same time point, calling the earlier evidence into question.¹⁴ For deep lesions in stage 4 disease, excision is generally preferred because ablation cannot reach tissue embedded several millimeters into the bowel or bladder wall. But for superficial peritoneal implants found alongside deeper disease, the choice between excision and ablation may matter less than the completeness of the overall surgery.

Hormonal and Medical Management

Not everyone with stage 4 endometriosis needs or wants surgery. Hormonal therapies aim to suppress the growth and activity of endometriotic tissue, and they are also commonly used after surgery to reduce the risk of recurrence.

Combined oral contraceptive pills and progestins (including the levonorgestrel intrauterine device) are first-line options. For patients who do not respond, newer oral GnRH antagonists have changed the landscape. Elagolix, tested in two large randomized trials, showed that at three months roughly three-quarters of women on the higher dose met clinical response criteria for period pain relief, compared to about one in five on placebo. The responses held at six months.¹⁵ Broader meta-analytic data on GnRH antagonists as a class support significant reductions in period pain, pain during sex, and non-menstrual pelvic pain.¹⁶

The main limitation of all hormonal therapies is that they suppress disease rather than eradicate it. Symptoms typically return when medication is stopped. Side effects vary by class: GnRH antagonists at higher doses can cause hot flashes and bone-density loss, which is why “add-back” therapy with small amounts of estrogen and progestin is sometimes used alongside them. Non-hormonal approaches, including anti-inflammatory drugs and experimental agents targeting blood vessel formation or inflammatory pathways, are being studied but none have yet replaced hormonal therapy in clinical practice.¹⁷

Fertility Considerations

Stage 4 endometriosis affects fertility through several pathways at once: adhesions can block or distort the fallopian tubes, endometriomas can damage the ovarian tissue that surrounds them, and the inflammatory environment of the pelvis can impair egg quality and embryo implantation. Many people with stage 4 disease turn to IVF.

A key concern is whether surgical removal of endometriomas helps or hurts fertility chances. Multiple well-designed studies consistently show that excising an endometrioma is associated with a decline in ovarian reserve, as measured by anti-Müllerian hormone (AMH) levels.¹⁸ The drop is more pronounced when both ovaries are operated on, and the surgical technique matters. A meta-analysis found that bilateral cystectomy caused a significantly greater AMH decline than vaporization techniques, and that using bipolar energy for hemostasis reduced AMH more than suturing or hemostatic agents did.¹⁹ Some recovery in ovarian reserve markers occurs over time, but levels rarely return to pre-surgery values. For this reason, many fertility specialists recommend freezing eggs or embryos before endometrioma surgery if pregnancy is a future goal.

When it comes to IVF stimulation protocols for women with advanced endometriosis, earlier studies suggested that prolonged suppression with GnRH agonists before starting stimulation (the “ultra-long” protocol) could improve pregnancy rates.²⁰ However, a randomized trial specifically testing this approach found no difference in cumulative delivery rates between the ultra-long protocol and the standard one, while the ultra-long group required more medication and longer stimulation.²¹ Current expert opinion holds that no single stimulation protocol has proven clearly superior for women with endometriosis, and that early intervention with any protocol offers good chances.²²

Recurrence After Surgery

Endometriosis is a chronic disease, and even thorough surgery does not guarantee it will stay away. In a long-term follow-up study of 358 women after ovarian endometrioma surgery, cumulative recurrence rates climbed from about 15% at five years to roughly 23% at ten years.²³ Younger age at surgery was a consistent risk factor for recurrence across multiple studies, as was more severe baseline pain.²⁴ One counterintuitive finding: becoming pregnant after surgery appears to be protective, significantly reducing recurrence risk. Coexisting adenomyosis (a related condition where endometrial tissue grows into the uterine muscle wall) also raised the chance of disease returning.

The role of postoperative hormonal therapy in preventing recurrence is less clear-cut than you might expect. One analysis found that patients who received postoperative medication actually had a higher recurrence rate than those who did not, though this likely reflects the fact that sicker patients are more likely to be prescribed ongoing treatment in the first place.²⁴ In other words, the medication prescription was a marker of severity, not a cause of recurrence. Most guidelines still recommend some form of hormonal suppression after surgery for patients not trying to conceive, even if the evidence base for its benefit is muddier than many people realize.

Central Sensitization and Why Pain Can Outlast the Lesions

A common and distressing experience for people with stage 4 endometriosis is that pain persists or even worsens after what their surgeon considers a successful operation. Part of the explanation lies in central sensitization: the nervous system itself can become rewired after years of chronic pain input. Research shows that women with endometriosis-associated chronic pelvic pain frequently develop widespread myofascial dysfunction and heightened pain sensitivity that extends well beyond the pelvis.²⁵ Pelvic floor muscle spasm may initiate or maintain this broader sensitization. When the nervous system itself has changed, removing the original lesions may not be enough. This is why many endometriosis specialists now incorporate pelvic floor physiotherapy, pain psychology, and sometimes medications targeting nerve pain into treatment plans alongside surgery and hormonal therapy.

The Diagnostic Delay Problem

People with endometriosis wait years for a correct diagnosis on average. A systematic review and meta-analysis identified two main buckets of delay: patients themselves often wait before seeking care (due to normalizing their pain, stigma around menstrual complaints, or lack of awareness), and providers frequently misdiagnose the condition or rely on non-specific tests that miss it.²⁶ Both patient-related and provider-related delays had similarly large effect sizes. For stage 4 disease specifically, the irony is that by the time someone receives a diagnosis, the disease may have been quietly scarring their pelvis for years. Raising awareness that cyclical bowel symptoms, pain with intercourse, and menstrual pain that does not respond to standard painkillers warrant further investigation could help close this gap.

Psychological and Quality-of-Life Effects

Living with stage 4 endometriosis is not just a physical experience. Anxiety, depression, and social isolation are common among people with the condition, and the psychological burden often compounds the physical one in a self-reinforcing loop: pain triggers distress, distress amplifies the perception of pain, and both erode the capacity to maintain work, relationships, and daily routines.²⁷ Integrated care models that combine surgical, medical, and psychological support tend to produce better outcomes than treating any one dimension in isolation. If you have been managing endometriosis with your gynecologist alone and still feel stuck, asking about referrals to a pain psychologist or a pelvic pain clinic with a multidisciplinary team is worth pursuing.

Dietary Approaches and What the Evidence Actually Shows

Many people with endometriosis experiment with dietary changes, and gluten-free diets are among the most popular. A retrospective analysis of 363 women with surgically confirmed endometriosis found that removing wheat or gluten led to improvement in pain scores, and when wheat was reintroduced, symptoms like pain, bloating, digestive disruption, headaches, and fatigue returned.²⁸ This is suggestive but far from conclusive. Retrospective, unblinded dietary studies are particularly prone to placebo effects and reporting bias. No randomized controlled trial has demonstrated that any specific diet changes the underlying disease. That said, if removing certain foods eases your symptoms and does not compromise your nutrition, the downside risk is low. Just be cautious about any provider or influencer framing diet as an alternative to medical treatment for advanced disease.